Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [7793]

Cancer-fighting cocktail demonstrates promising results as treatment for advanced cervical cancer

Cancer-fighting cocktail demonstrates promising results as treatment for advanced cervical cancer

ASTRO: Cancer patients with malignant spinal cord compression have preserved mobility

ASTRO: Cancer patients with malignant spinal cord compression have preserved mobility

ASTRO: Chemotherapy and SABR consecutively may be promising treatment option for advanced pancreatic cancer

ASTRO: Chemotherapy and SABR consecutively may be promising treatment option for advanced pancreatic cancer

$ASTRO: Prostate cancer patients who receive hypofractionated RT report consistent QoL$

ASTRO: Prostate cancer patients who receive hypofractionated RT report consistent QoL

ASTRO: Prostate cancer patients surveyed 5 years after vessel-sparing RT report preserved sexual function

ASTRO: Prostate cancer patients surveyed 5 years after vessel-sparing RT report preserved sexual function

ASTRO: Select group of stage IV lung cancer patients achieve long-term survival after aggressive treatments

ASTRO: Select group of stage IV lung cancer patients achieve long-term survival after aggressive treatments

Epigenetic drugs: A hope to treat cancer resistance and reduce cancer relapse?

Epigenetic drugs: A hope to treat cancer resistance and reduce cancer relapse?

ASTRO: Study identifies when and how much various prostate cancer treatments will impact urinary and sexual functioning

ASTRO: Study identifies when and how much various prostate cancer treatments will impact urinary and sexual...

ASTRO: Benefit of endocrine therapy in elderly women with low risk hormone receptor positive breast cancer

ASTRO: Benefit of endocrine therapy in elderly women with low risk hormone receptor positive breast cancer

Patients with head and neck cancers resistant to cetuximab may benefit from an investigational drug

Patients with head and neck cancers resistant to cetuximab may benefit from an investigational drug

More from ecancer